Navigation Links
2 Genes Implicated in Autism
Date:2/9/2009

Finding might lead to better diagnosis, treatment, study suggests

MONDAY, Feb. 9 (HealthDay News) -- Multiple, interacting genetic risk factors may influence the severity of autism, a new study suggests.

Massachusetts Institute of Technology researchers said they've pinpointed two genes that cause autism-like symptoms in mice. The findings support a long-held theory that more than one gene is involved in people with genetic-based autism.

The researchers said their discovery could lead to the development of drugs that target signaling mechanisms between genes that interact to cause some symptoms of autistic spectrum disorders (ASDs).

The study found that mice with mutations in two different candidate autism susceptibility genes -- PTEN and the serotonin transporter gene -- had more severe symptoms than mice with only a single mutation. Mice with a mutation in PTEN alone or in the serotonin transporter gene alone had brains that were larger than normal, while mice with mutations in both genes had even larger brains.

About 24 percent of people with autism have larger-than-normal brain size. In people with ASDs, brain size is correlated with the severity of behavioral problems, the researchers said.

The MIT study also found that female mice with a mutation in the PTEN gene had impaired sociability, and those with mutations in both PTEN and the serotonin transporter gene had more severe symptoms.

"We found that two genetic risk factors for ASDs act cooperatively in mice to influence brain size and social behavior, both of which are altered in ASDs," lead investigator Damon T. Page, a postdoctoral fellow at MIT's Picower Institute for Learning and Memory, said in an MIT news release.

"Our results provide evidence that the severity of autistic symptoms may be the product of variations in DNA in multiple locations in the genome," Page added.

The study was published in the F
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Genesis Successfully Defends Multi-Million Dollar Arbitration Filed by CRG and CRGP; Related Parties Withdraw Remaining Demands for Arbitration Against Genesis
2. Genesis Pharmaceuticals Successfully Defends Itself in a Multi-Million Dollar Arbitration, Two Other Arbitration Proceedings Against Genesis are Withdrawn
3. New genes involved in acute lymphoblastic leukemia play fundamental role in prognosis of the disease
4. Angiogenesis linked to poor survival in patients with rare type of ovarian cancer
5. Penn study finds link between Parkinsons disease genes and manganese poisoning
6. Genesis Pharmaceuticals Enters Into Agreement to Purchase Hongrui Pharmaceuticals, and Acquire 22 New Traditional Chinese Medicines
7. Cardiogenesis Announces Successful Educational Symposium at Society of Thoracic Surgeons Meeting in San Francisco
8. In Kids, Genes May Affect Leukemia Treatment
9. Popular or Not? Your Genes May Help Decide
10. Common Genes Link Bipolar Disorder, Schizophrenia
11. UCSF Researchers Use New Tools to Move in on Cancer Susceptibility Genes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... The American Academy of...an 75,000 clinically practicing physician assistan... the U.S. House of Representatives for passing Sat...Affordable Health Care for America Act. ,, "We ...l ultimately lower the cost of health care and gre...
(Date:11/9/2009)...use funds to move lab findings into human therapy ...n from nerve damage ,, ANN ARBOR, Mich., Nov. ...niversity of Michigan Department of Neurology have...therapy for neuropathic pain, a difficult-to-treat...se of damage to nerve without obvious tissue injur...
(Date:11/9/2009)...ble in French . , , Montreal, November 9, 20...emale. In human bodies trillions of cells are coup... are composed. Yet these don,t come in twos, they...cause these complex cell networks are the backbone...ed for ways to splice cell clusters down to their ...
(Date:11/9/2009)...9, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the ...announced the availability of INTUNIV (guanfacine)... United States for the treatment of Attention-Defi...adolescents ages 6 to 17. INTUNIV, a once-daily f...nscheduled alpha-2A receptor agonist approved for ...
(Date:11/9/2009)...eople around the world suffer from cataracts. Thom...d his coauthors discuss cataract surgery with the ...issue of Deutsches rzteblatt International ( Dts...lindness is usually due to opacification of the le...perations are performed each year. Cataracts can b...
Breaking Medicine News(10 mins):Health News:American Academy of Physician Assistants Applauds U.S. House of Representatives for Passing Health Care Reform Bill 2Health News:U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4
...arry Minnix, President & CEO, American Association...ation of the Medicare Therapy,Caps Exceptions Proc...,from Larry Minnix, President & CEO, American Asso...in having their physical and,occupational therapy ...
... The American Medical,Association (AMA) Foundation...ysician association, recently named several new bo...ers:, -- Jean Howard, Traverse City, MI, Preside...aynard, M.D., Evansville, IN, Secretary, New Mem...
...l sunscreen available at retailers nationwide and ... , ORLANDO, Fla., July 2 Caribbean Solutions,( h...een, Caribbean Sol,SolGuard SPF 25 and Kids Kare 2...ttp://www.newscom.com/cgi-bin/prnh/20080702/LAW520...
... only to childbirth as most common reason for hosp..., July 2 (HealthDay News) -- In 2006, more than 1....opulation of Dallas -- were hospitalized for pneum...mission to hospital, and treating these lung infec...
...Technologies from Los Alamos National Laboratory ... Airplanes, Cars Go On a Nanotechnology ...fics (Pink Sheets: MHTX) announced today that it h...enator,Jeff Bingaman said, "I believe the merger o...
...(July 2, 2008) - Measuring calcium deposits in the...isk in American adults, even when they are elderly...ssue of Journal of the American College of Cardio...l Center (LA BioMed), said previous studies had fo...
Other Medicine News:Health News:AAHSA Statement: Therapy Caps Ration Care 2Health News:Caribbean Sol Biodegradable Sunscreen Gets Strong Safety Rating From Environmental Working Group 2Health News:Manhattan Scientifics Acquires Metallicum, Inc. 2Health News:Manhattan Scientifics Acquires Metallicum, Inc. 3Health News:Manhattan Scientifics Acquires Metallicum, Inc. 4Health News:New study finds coronary arterial calcium scans help detect overall death risk in the elderly 2
(Date:11/9/2009)..., MIAMI, Nov. 9 ISTA P...nced additional results from the Company,s Bepreve...5% Phase 3 clinical studies. These results were p...ting of the American College of Allergy, Asthma &a...In a poster presentation titled, "Treatment of Ocu...
(Date:11/9/2009)..., SUNNYVALE, Calif., Nov. 9 /PRNewswire-FirstCal...harmaceutical company focused on developing and co...the treatment of immune mediated diseases and canc...sident, Preclinical Development will provide an ov... Merriman Curhan Ford,s 6th Annual Investor Summit...
(Date:11/9/2009)..., SOUTH SAN FRANCISCO, Calif., Nov. 9 /PRNewswir...ay announced that on November 5, 2009, it received...q") stating that the Nasdaq Hearing Panel has gran... NASDAQ Global Market subject to the condition tha...er 31, 2009, the proposed merger (the "Merger") co...
Breaking Medicine Technology:ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 2Anesiva Receives Positive Nasdaq Hearing Panel Determination for Continued Listing 3David Yap receives Amethyst Award 51065 1LocumTenens com Expands Service Lines to Include Primary Care 51062 1LocumTenens com Expands Service Lines to Include Primary Care 51062 2LocumTenens com Expands Service Lines to Include Primary Care 51062 3Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients 51057 1Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients 51057 2Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients 51057 3Insite Security Partners With WorldClinic to Offer Global Medical Support to Clients 51057 4
...3 Telik, Inc.,(Nasdaq: TELK ) announced it will ... of TELINTRA(R) (ezatiostat HCl) Tablets at the 49...ology. The presentation is,scheduled for Saturday,...,and B4 at the Georgia World Congress Center in At...608) is titled: "Phase 1 Dose Escalation Study of,...
...ance to Phase III Clinical Trial, PALO ALTO, Cali...d: AVGO), a late-stage biotechnology company that,...eurodegenerative,diseases, today announced positiv...AL-08, the Company,s second generation proprietary...ose of the trial was to determine which,of two com...
Other Medicine Technology:Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 2Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 3Avicena Announces Positive Phase II Data for a Combination Trial Involving AL-08 for the Treatment of Amyotrophic Lateral Sclerosis (ALS) 4
Steroid 21-Hydroxylase (21-OH) Autoantibody RIA
...ELISA test kit is intended for the quantitative de...This exceptionally sensitive ELISA procedure offer...y), providing for accurate establishment of post-a...ventional methods. Furthermore, with the ability t...
...r use with 4, 8, or 12 channel pipettors. Angled s...rly all of the solution. Corners have pouring lips...rgin polystyrene containing no regrinds. Sterile 5...y irradiation. Dimensions: 78 mm W x 152 mm L x 35...
Sterile Individually Packed 100 mL Solution Basins
Medicine Products: